Ng SC, et al. Therapeutic strategies for the management of ulcerative colitis. Inflamm Bowel Dis 2009; 15(6): 935-50.

R Srivastava, et al. Effect of curcumin on platelet aggregation and vascular prostacyclin synthesis. Arzneimittelforschung 1986; 36(4): 715-7.

Taylor RA, et al. Curcumin for inflammatory bowel disease: a review of human studies. Altern Med Rev 2011; 16(2): 152-6.

Teayoun K, et al. Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells. Biochem Biophys Res Commun 2009; 388(2): 377-82.

Usharani P, et al. Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study. Drugs R D. 2008; 9(4): 243-50.

Yasunari Takada, et al. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene 2004; 23(57): 9247-58. (piperine enhancing curcumin by 2,000%) (curcumin group had a 65% decreased risk of heart attack) ontamination_FDA_recall.html # by-increasing-intestinal-b